Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Gleevec/Glivec

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Gleevec/Glivec was produced by Novartis.

New drugs can't keep Novartis sales on the up

New drugs can't keep Novartis sales on the up compensate for a $290m reduction in sales of cancer drug Glivec (imatinib) to $544m, with overall group sales down 1% to $11.53bn.

Novartis 'reviewing options' for Alcon division

Novartis 'reviewing options' for Alcon division year. The company is expecting 2017 to continue to be pressured as former top-selling cancer drug Glivec/Gleevec (imatinib) continues to face generic competition, with a return to growth next

Takeda agrees $5.2bn deal to buy Ariad

Takeda agrees $5.2bn deal to buy Ariad The multi-targeted tyrosine-kinase inhibitor drug is facing stiff competition from other drugs in the class including Novartis' Glivec/Gleevec (imatinib) and generic equivalents in some markets.

NICE backs BMS leukaemia drug Sprycel

NICE backs BMS leukaemia drug Sprycel to 66% of patients taking Novartis' Gleevec (imatinib), the current standard care. ... With a list price of £30, 000 per patient per year, Sprycel was originally rejected due to its lack of cost-effectiveness, and NICE approved the cheaper Gleevec.

Novartis says its biosimilar sales should reach $1bn this year

Novartis says its biosimilar sales should reach $1bn this year The biosimilar franchise helped Novartis shrug off a second quarter of generic competition for its cancer drug Gleevec in the US, a lacklustre performance from its Alcon eyecare division and less

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Origins Insights

Our goal is to identify and embed transformational patient insights as a fundamental part of the drug development process. As...

Latest intelligence

Want to give perfect client service? Tough luck, you’re human
In this article an ex-client of mine, Liz Skrbkova, and I explore the (unhelpful) pressures of trying to perfect the client-agency relationship...
WHITE PAPER: Why do men die younger?
It’s a commonly accepted fact that women outlive men. Wherever you live, there’s a good chance that men will die on average eight years earlier than women. Is this an...
3 tips to show patient diversity in your clinical trial materials
Here are some useful tips to help get your hands on authentically diverse stock photos....

Infographics